Live Chat

Novavax gráfico en tiempo real

instrument_fundamentals

Weekly Search
Weekly
Daily
Date Cerrar Change Cambio del % instr__open Alto Bajo

Markets.com news

bitcoin rising
Alec Malloy 2024 Aug 19, 16:05

Test News Spanish Article Only

BoE Acciones
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Adelanto semanal: Los resultados de las elecciones francesas clave para los mercados europeos

Forex Índices
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Adelanto semanal: ¿Francia desencadenará la próxima crisis del euro?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Adelanto semanal: Muchos datos e información sobre la inflación

Forex Índices

Información

Spread

0.07

Spread (%)

0.7609 %

Apalancamiento

1:10

Interés a un día (Compra)

-0.0597 %

Interés a un día (Venta)

-0.0292 %

Divisa

USD

Horarios de los mercados

Market open

Martes

14:31 - 20:59

Lunes

14:31-20:59

Miércoles

14:31-20:59

Jueves

14:31-20:59

Viernes

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1383998336

instr__shares_outstand

160184992

instr__earnings_date

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

instr__eps

-2.18

instrument_learn_more

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

related_instruments

Activo
Vender
Comprar
Cambio del %
view_all_instruments
Trustpilot
Live Chat